FDA prohibits Sun Pharma's Halol Plant from exporting drugs to US
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
Marksans Pharma gets USFDA nod for acid reflux drug
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The inspection was conducted from July 22-25, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Subscribe To Our Newsletter & Stay Updated